Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 1/20 | 0.33 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27244942 | 1.00 | GRM2 (0.33) | GRM2GRM3ATM | |
| SCHEMBL25335347 | 0.82 | ATM (0.33) | GRM2GRM3ATM | |
| SCHEMBL27245076 | 0.82 | GRM2 (0.33) | GRM2GRM3ATM | |
| SCHEMBL27244972 | 0.76 | GRM2 (0.39) | GRM2GRM3 | |
| SCHEMBL28700890 | 0.72 | — | — | |
| SCHEMBL1251097 | 0.72 | APLNR (0.35) | GRM2GRM3ATM | |
| SCHEMBL1251101 | 0.72 | APLNR (0.35) | GRM2GRM3ATM | |
| SCHEMBL1251099 | 0.72 | APLNR (0.35) | GRM2GRM3ATM | |
| SCHEMBL27244747 | 0.71 | GRM2 (0.33) | GRM2GRM3 | |
| SCHEMBL27244937 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199647-A1 | ANTI-VIRAL COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2024-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199647-A1 | ANTI-VIRAL COMPOUNDS | EIF2AK2, ZC3HAV1, HAVCR2 | GRM2 4679/4885GRM3 4583/4885ATM 4728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.